Loader

Pathways

PathWhiz ID Pathway Meta Data

PW064750

Pw064750 View Pathway
signaling

SDMA Signaling

Homo sapiens

PW146330

Pw146330 View Pathway
drug action

Sea salt Drug Metabolism Action Pathway

Homo sapiens

PW146561

Pw146561 View Pathway
drug action

Secnidazole Drug Metabolism Action Pathway

Homo sapiens

PW176175

Pw176175 View Pathway
metabolic

Secnidazole Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Secnidazole are predicted with biotransformer.

PW128413

Pw128413 View Pathway
drug action

Secobarbital Action Pathway

Homo sapiens
Secobarbital is a barbiturate derivative that serves as a short-term treatment for insomnia, offering an array of properties including anesthesia induction, anticonvulsant effects, and sedative-hypnotic capabilities. It finds use in inducing anesthesia before other general anesthetic agents and for brief surgical, diagnostic, or therapeutic procedures with limited painful stimuli. While barbiturates like secobarbital don't provide significant analgesia and might even incite excitation in the presence of pain, their metabolization primarily occurs through the hepatic microsomal enzyme system, with resultant metabolites being excreted mainly through urine, and occasionally through feces. Overdose manifestations encompass lethargy, lack of coordination, cognitive impairment, slowed speech, impaired judgment, drowsiness, shallow breathing, instability, and, in severe instances, potential progression to coma and fatality.

PW144543

Pw144543 View Pathway
drug action

Secobarbital Drug Metabolism Action Pathway

Homo sapiens

PW176134

Pw176134 View Pathway
metabolic

Secobarbital Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Secobarbital are predicted with biotransformer.

PW122258

Pw122258 View Pathway
metabolic

Secondary metabolites pathways

Bacteria

PW122259

Pw122259 View Pathway
metabolic

Secondary metabolites pathways 1539851941

Bacteria

PW000977

Pw000977 View Pathway
metabolic

Secondary Metabolites: Cysteine Biosynthesis from Serine

Escherichia coli
The pathway starts with a 3-phosphoglyceric acid interacting with an NAD driven D-3-phosphoglycerate dehydrogenase / α-ketoglutarate reductase resulting in an NADH, a hydrogen ion and a phosphohydroxypyruvic acid. This compound then interacts with an L-glutamic acid through a 3-phosphoserine aminotransferase / phosphohydroxythreonine aminotransferase resulting in a oxoglutaric acid and a DL-D-phosphoserine. The latter compound then interacts with a water molecule through a phosphoserine phosphatase resulting in a phosphate and an L-serine. The L-serine interacts with an acetyl-coa through a serine acetyltransferase resulting in a release of a Coenzyme A and a O-Acetylserine. The O-acetylserine then interacts with a hydrogen sulfide through a O-acetylserine sulfhydrylase A resulting in an acetic acid, a hydrogen ion and an L-cysteine